Preclinical Imaging In Vivo Market Trends, Opportunities, and Forecast by 2031

MARKET OVERVIEW

Preclinical Imaging (In-VIVO) Market size will witness a substantial growth in the forecast period with rising investments for monitoring treatment response for early disease diagnosis along with cancer cell detection, bio distribution and drug target. Preclinical imaging (In-VIVO) is gradually used across several drug development processes, with applications ranging from compound optimization, to target identification studies. The use of preclinical imaging (In-VIVO) across several domains will boost the market growth.

MARKET SCOPE

The "Global Preclinical Imaging In Vivo Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Preclinical Imaging In Vivo market with detailed market segmentation by modalities, reagents and geography. The report provides key statistics on the market status of the leading Preclinical Imaging In Vivo market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•   Based on modality, the global Preclinical Imaging In Vivo market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems and Others.
  
•   Based on Reagents, the market is categorised into Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, MRI Contrast Agents, and CT Contrast Agents.
  

MARKET DYNAMICS

Drivers

•   Technological innovations such as combination of high resolution MRI with other imaging modalities.
  
•   Increasing amount of funding and public-private initiatives in preclinical research activities.
  

Restraints

•   High product price leading to decreased adoption rates among academic and research institutions and limited application of each modality.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Preclinical Imaging In Vivo market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Preclinical Imaging In Vivo market in these regions.

IMPACT OF COVID-19 ON PRECLINICAL IMAGING IN VIVO MARKET

As a result of the COVID-19 pandemic many radiology departments have experienced a rapid decline in imaging case volumes. This has important implications on the short-term and long-term economic stability of preclinical imaging procedures across all healthcare practice settings. Due to lockdown imposed by the governments across the world many preclinical procedures were delayed, and supply chain restriction has limited the availability of resources needed to deliver imaging services. Moreover, the COVID-19 pandemic has disrupted the pace of preclinical trials, including delaying diagnoses and therapeutics and in few cases halting clinical trials.

MARKET PLAYERS

The report covers key developments in the Preclinical Imaging In Vivo market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Preclinical Imaging In Vivo market are anticipated to lucrative growth opportunities in the future with the rising demand for Preclinical Imaging In Vivo in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Preclinical Imaging In Vivo market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•   Takara Bio
  
•   Bruker Biospin
  
•   Carestream Health
  
•   PerkinElmer
  
•   Evrogen
  
•   Agilent Technologies
  
•   BD Biosciences
  
•   Berthold Technologies
  
•   GE Healthcare
  
•   Nikon
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Preclinical Imaging In Vivo Report Scope